Skip to content

A Study on the Effects of Soulera Herbal Blend Intake on Chronic Stress in Healthy Adults

A Pilot Double-Blind Crossover Study on the Effects of Soulera Herbal Blend Intake on Chronic Stress and Its Biomarkers in Healthy Adults

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01299402
Enrollment
64
Registered
2011-02-18
Start date
2011-08-31
Completion date
2012-09-30
Last updated
2012-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stress

Brief summary

The purpose of the study was designed to evaluate the efficacy and safety of Soulera herbal mix in powder form and its effects on anxiety and the biomarkers for chronic stress.

Interventions

DIETARY_SUPPLEMENTSoulera Herbal Blend

This a powder blend of various reputed adaptogenic herbs. The dosage will be one 8.6 gram powder sachet daily.

DIETARY_SUPPLEMENTPlacebo

The placebo will be a similar tasting and looking powder blend as the Soulera Herbal Blend. The dosage will be 8.6 grams per sachet daily.

Sponsors

LeraPharm Inc.
CollaboratorINDUSTRY
Joseph Pergolizzi, MD
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women between the ages of 21-65. * No concerns that would confound the study as determined by study physicians. * Women must not be pregnant or become pregnant for the duration of the study.

Exclusion criteria

* The subject has a history of hypersensitivity to any of the compounds used in the study * The subject is pregnant or breast feeding. Note: If the potential subject is a post-menarche female, a urine pregnancy test must be performed within 24 hours prior to study drug administration and confirmed negative in order for the potential subject to eb enrolled. * History of Psychiatric Illness or Chronic Stress or Anxiety * Hypertension, cardiovascular disease, liver, hypokalemia, or kidney disease or other health concerns that the study physician feels may confound study results * Individuals who are cognitively impaired or who are not able to give informed consent * Any routine prescription medication that the study physician feels may cause drug interaction with Soulera or alter the prescription medications' activity * Previous participation in a clinical research trial within 30 days prior to randomization * The subject has an ongoing abuse of illicit substances, alcohol, or actively smoking marijuana * The subject uses or has used in the past 30 days any steroid formulation, be it topical like face cream, ocular as in an eye drop, nasal as in a spray, injection or pill. * The subject is a current smoker or uses tobacco products such as chewing tobacco. * The subject is actively engaging in the use of Herbal Medicine, Traditional Chinese Medicine, Ancient Indian Medicine, Yoga, or Ayurveda * The subject is a night-shift worker and therefore presumably has an altered cortisol diurnal rhythm and is also unable to comply with the required cortisol collection times of the study

Design outcomes

Primary

MeasureTime frameDescription
Salivary Cortisol Levels14 WeeksChange in salivary cortisol as stress biomarkers for the chronic stress response following Soulera Herbal Blend intake

Secondary

MeasureTime frameDescription
Change in chronic stress6 times during 14 weeksThe State-Trait Anxiety Test will be given to measure the change in both chronic stress and anxiety.(
Quality of Life Questionaire6 times during 14 weeksA survery to measure your quality of life.
Spot Urine Potassium Test6 times during 14 weeksA spot urine test will be conducted to determine potassium level. Only the potassium will be measured in the urine.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026